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a  b  s  t  r  a  c  t
PCR  is a well-understood  and  established  laboratory  technique  often  used  in molecular  diagnostics.  Huge
experience  has been  accumulated  over  the  last  years  regarding  the  design  of  PCR  assays  and  their  set-up,
including  in-depth  troubleshooting  to obtain  the  optimal  PCR  assay  for  each  purpose.  Here  we  report
a  PCR  troubleshooting  that came  up with  a surprising  result  never  observed  before.  With  this  report
we  hope  to sensitize  the  reader  to  this  peculiar  problem  and  to  save  troubleshooting  efforts  in similareywords:
CR
T-PCR
eal-time PCR
CR diagnostic
roubleshooting
situations,  especially  in time-critical  and  ambitious  diagnostic  settings.
©  2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).eaction mix
. Introduction
During the past years PCR has become the gold standard for
he molecular diagnostics of manifold diseases, such as cancer
r infectious diseases. In most cases real-time PCR applications
ave replaced conventional PCR tests due to their obvious ben-
ﬁts, namely speed, increased speciﬁcity, (semi-) quantiﬁcation,
educed work-load, and a minimized risk of carry-over contami-
ation, which is of beneﬁt especially in diagnostic labs [1,2].
Consequently several standardized PCR kits for most clinically
mportant and frequently needed molecular targets have been
ade commercially available by several manufacturers. However,
here are at least as many PCR applications in the ﬁeld of PCR diag-
ostics for which there is no real market and unfortunately no
ommercially available kits are being developed. This applies for
xample to the ﬁeld of neglected as well as new and emerging infec-
ious diseases. For these issues usually in-house assays have to be
stablished and validated by expert laboratories, which can only be
s good as it is technically feasible regarding the often low isolate
umbers available.
The manufacturer and the speciﬁcations of PCR components
sed in in-house PCR assays have to be selected by the user who,
n general, relies on his previous experience. Components that are
ommon to any PCR and are present in the basic reaction mix  are
he enzyme for PCR or RT-PCR, the buffer required for the enzy-
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.0/).matic reaction, Mg2+ or other bivalent ions, dNTPs or derivatives,
water, and ﬁnally as target-speciﬁc ingredients primers and probes.
The basic reaction mix  can be set up from all mentioned individual
components. In this context, there is a kind of unwritten law that
everyone who  has set up PCR reactions by themselves has expe-
rienced trouble with ampliﬁcations that somehow unexplainably
fail. The reason for PCR failure is usually rapidly identiﬁed. Often
problems can be explained by the fact that essential components
like Mg2+ ions or even primers were of poor quality because the
expiration date has passed or were unintentionally not added to the
reaction mix. The PCR set-up is then started from scratch with new
aliquots of components and in most cases the problem is solved.
A well-accepted approach to reduce the risk of making an error
in preparing the basic PCR mix  is the utilization of a ready-to-use
mastermix that contains all components except for the primers and
the probe(s). These ready-to-use mixes have become popular since
they contribute to a certain level of standardization and speed up
and ease hands-on times.
However, also ready-to-use basic mixes can be subject to a vary-
ing PCR performance and have to be controlled for functionality. For
example, in compliance with quality management, a new batch of
a reagent has to be compared with the old one in the same run with
the same assay. As long as the results obtained are not different, the
new reagent batch is accepted as fully functional.
Here we describe a PCR “case report” with unexpected results
in a routine PCR troubleshooting.
Our division deals with the diagnostics of various highly
pathogenic viruses, with real-time PCR as the most popular
approach. One pillar of this diagnostic portfolio is one-step real-
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Table 1
Troubleshooting of the failed PCR reaction for Lassa virus [5].
Suspected reason Measures Ampliﬁcation
Human error Repetition of all PCRs No
Failure of the positive control Use of new aliquots of in vitro transcribed RNA and plasmid DNA also
highly concentrated
No
Primer and probe damage Use of fresh primer and probe aliquots resolved and previously tested
to be working properly
No
Primer and probe damage Use of fresh lyophilized aliquots of primers and probes No
Problem with the basic reaction mix  from manufacturer A Use of new aliquot of the basic one-step RT-PCR mix from
manufacturer A (although the aliquot used proved to work for YFV
RT-PCR)
No
Inhibiting inﬂuence of water Test of freshly opened PCR water aliquots No
Individual problem of the cycler A different ABI 7500 cycler was  used (although the used one proved to
work for YFV RT-PCR)
No
Problem of the ABI7500 series Parallel PCR runs on various real-time PCR cyclers including ABI 7500,
ABI StepOneTM and Roche LightCycler® 480
No
Individual problem with the Lassa virus assay Application of another LASV-speciﬁc RT-PCR targeting a different
region of the same gene
No
Problem with the PCR enhancer Parallel PCRs with and without enhancer No
Problem with the reaction plates Use of plates from a different manufacturer No
se of a
se of r
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R
ime RT-PCR-based detection of viruses causing hemorrhagic fever,
ike Ebola virus (EBOV), Marburg virus (MARV), Lassa virus (LASV),
ellow fever virus (YFV), and viruses relevant for differential diag-
osis. For those viruses, for which there are no commercially
vailable kits and also for conﬁrmation of positive results obtained
y using kits, we apply in-house tests using a basic one-step RT-PCR
eaction mix  from a manufacturer A. These assays are thoroughly
alidated with this reaction mix. According to quality management
ules, we always compare a new batch of the basic reaction mix  with
he old one. Since there are currently about 40 validated in-house
T-PCR assays in our portfolio, not every single assay is subjected
o comparison, but some in-house assays are selected exemplarily
nd compared.
. The case
In a routine request to exclude relevant viral hemorrhagic fevers
n a hospitalized patient we received serum to run PCRs for EBOV,
ASV and YFV. Usually these requests are urgent, due to the pub-
ic health precautions potentially required for highly contagious
atients. RNA was extracted from serum using the Viral RNA Mini
it to which the Internal Control (IC) provided with the RealStar®
ilovirus Screen RT-PCR Kit 1.0 (altona Diagnostics) was added
ccording to the manufacturer’s instructions. As negative control,
etal Calf Serum (FCS) was extracted and spiked with the IC in par-
llel. We performed the EBOV PCR using the Filovirus Screen Kit,
btaining a negative result within 2 h. The IC showed perfect ampli-
cation curves with similar Cq values of about 31 for the clinical
ample as well as for the FCS control, thus conﬁrming successful
xtraction and RT-PCR reaction and also ruling out sample-speciﬁc
CR inhibition. In parallel, we set up in house one-step RT-PCRs
or the detection of YFV and LASV using published assays [4,5]. For
hese assays we routinely use a basic one-step RT-PCR reaction mix
rom manufacturer A. Both assays were set up in parallel using the
ame aliquot of water and reaction mix  and were run in parallel
n the same Applied Biosystems 7500 Real-Time PCR Instruments.
he sample was negative for YFV with perfectly ﬁne ampliﬁcation
urves for the positive control (in vitro transcribed RNA). In con-
rast, the LASV assay did not show any ampliﬁcation, neither for
he sample nor for the positive control. Even on an agarose gel no
mpliﬁcation of the positive control could be shown. Since these
esults could not be explained easily, we started troubleshooting basic one-step RT-PCR from another manufacturer B Yes
emaining failing, old aliquot of the preferred basic one-step
 mix  from manufacturer A
Yes
by checking 12 parameters [3], which were sometimes combined
in one run. Table 1 summarizes the troubleshooting activities.
As shown in Table 1, all obvious possible measures were taken
without success. Even measures that were not the ﬁrst choice failed
to restore the PCR assay. Only when we  used a basic one-step RT-
PCR reaction kit from another manufacturer B, we could observe
ampliﬁcation as expected. At this point we need to point out that
the Lassa virus PCR assay was well validated with the preferred
basic PCR kit from manufacturer A which turned out to be superior
to the kit from manufacturer B in terms of detection limit in our
validation process. Hence, this result was unexpected and surpris-
ing. However, it led us to the idea to test an aliquot from an old
batch of the kit from manufacturer A and we were again surprised
that this old aliquot worked as expected.
While the old batch worked for every single one of our assays
tested, the new batch only worked for some assays, e.g., the YFV
assay [4], but not for others, e.g., the LASV and West Nile virus assays
[5,6] .
Interestingly, considering the rules for PCR design and assess-
ment, we were unable to identify any physical parameter of the
primers like Tm, GC-content, Hairpin Tm or degree of degener-
acy that would allow us to predict the sensibility of an assay to
obviously slightly changing reaction conditions with the new batch.
As described above, comparing old and new batches always con-
trols a change of a reagent’s batch. However, not all of the 40 assays
can be compared, for economic reasons and because of a restriction
in batch size and stability. So far, we have been assuming that the
proof of functionality of a new reagent batch for an assay selec-
tion is sufﬁcient evidence of the quality of the new reagents batch.
This does not seem to be true for all individual assays. Therefore
we wanted to share the lessons learnt with the PCR community,
particularly with those who  need to rely on rapid PCR-based diag-
nostic results, hoping to add a new troubleshooting criterion to the
recent check list.
According to the manufacturer of kit A, the new batch passed
the QM check and no other customers reported similar problems.
However, fair enough, the company fully compensated the lost
reagents.3. Conclusions
Summing up, we found that (i) different PCR assays show indi-
vidual sensitivity toward changes in the reaction mixture. Again, we
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re not talking about new reaction conditions, but about expect-
dly the same reaction conditions and just a batch change of the
ame product. (ii) Since some of the assays were absolutely iden-
ical in performance after the batch change, conclusions drawn on
ne assay can not be transferred to another one. (iii) The detri-
ental effect of a new batch can result in a complete failure of
mpliﬁcation. Minute changes in buffer substitutions usually result
n reduced PCR performance, but not in a complete failure. (iv)
atch changes should be controlled individually for every assay. To
educe costs and workload, large batches of the respective reagents
hould be purchased. (v) Preparing important PCR assay protocols
or reagents from more than one manufacturer may  help to assure
apid reliable diagnostics. In our case, we were still able to report
he negative result in time.
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